AVPT vs TSAT

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite solid revenue growth (23.6% YoY) and strong gross margins (74.51%), profitability remains thin with only a 0.50% net margin and weak ROE (0.67%). Analysts recommend a 'buy' with a $19.02 target, implying 51% upside, but insider selling of $89.11M over the last six months contradicts this optimism. The stock trades at a high forward P/E of 32.18, above sector averages, while recent price performance is bearish (-31.3% over 1Y), reflecting market skepticism despite improving earnings trends.

TSAT exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a critical liquidity crisis evidenced by a Current Ratio of 0.25. Despite a massive 1-year price surge of 242.4%, the underlying fundamentals are deteriorating, with revenue contracting by 26.5% YoY and net profit margins at -37.17%. The disconnect between the current price ($53.08) and the company's inability to cover short-term obligations suggests a speculative bubble or high-risk volatility. The technical trend has now shifted to heavily bearish (10/100), signaling a likely correction.